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ABSTRACT OF THE THESIS 
 
Efforts Towards the Synthesis of Ceylonamide A via a Stereocontrolled Polyene Cyclization 
By 
 
Glynis Longworth Coyne 
 
Master of Science in Chemistry 
 
University of California, Irvine, 2019 
 
Professor Christopher D. Vanderwal, Chair 
 
 
This thesis describes efforts made towards the synthesis of ceylonamide A via a 
stereocontrolled cationic polyene cyclization. Chapter 1 provides background on the ceylonamide 
family of natural products and reviews the use of cationic polyene cyclizations as a general 
synthetic approach. This chapter reviews a particular cyclization methodology recently reported 
by the Vanderwal group which allows for a new mode of access to specific polycyclic structural 
motifs. A novel application of this technology is proposed towards the synthesis of the bioactive 
diterpene ceylonamide A. 
Chapter 2 discusses the efforts made towards the synthesis of ceylonamide A. The 
preparation of a key intermediate and attempts to carry out the desired cyclization are described. 
In addition, control studies to investigate the confounding factors of this cyclization are detailed, 
along with the synthesis of the substrates utilized in each experiment. 
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CHAPTER 1: Background on the Ceylonamide Natural Products and 
Cationic Polyene Cyclizations 
 
 
1.1 Introduction 
The ceylonamides are a class of nitrogenous tetracyclic spongian diterpenes whose 
isolation was first reported by Tsukamoto and coworkers in 2016 from the Indonesian marine 
sponge Spongia ceylonensis (Figure 1.1).1 These tetracyclic compounds are composed of three cis-
fused 6-membered rings, with oxygenation of the axial (C19) methyl carbon on the A-ring, and a 
characteristic α,β-unsaturated γ-lactam D-ring, with oxygenation at either C15 or C16 (Figure 1.1). 
They are part of the general class of spongianes,2 and structurally similar molecules in this family 
have been previously reported, including haumanamide, reported by Scheuer and coworkers in 
1992 (1.7),3 and the spongolactams A–C, reported by Ojika and coworkers in 2007 (1.8–1.10).4  
Figure 1.1: Ceylonamides A–F and related terpenes 
 
From a bioactivity standpoint, Tsukamoto and coworkers found that ceylonamides A and 
B (1.1 and 1.2, respectively) exhibited inhibitory activity towards receptor activator of nuclear 
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factor-κB ligand (RANKL); stimuli from this ligand activate downstream signaling pathways 
which result in the up-regulation of osteoclastogenesis.5 Thus, these molecules represent possible 
candidates for the suppression of bone breakdown by osteoclasts, particularly ceylonamide A (IC50 
= 13 μM; ceylonamide B, IC50 = 18 μM). A variety of bone density-related disorders, such as 
osteoporosis, bone metathesis, and some bone cancers have been linked to malfunctions in 
osteoclast regulation, especially with respect to RANKL activity.5-7 In addition, RANKL inhibition 
has been shown to have anti-tumor effects;8 as a result, RANKL-inhibiting drugs have become of 
major clinical interest.6  
1.2 Cationic polyene cyclizations 
Cationic polyene cyclizations have been well-established as powerful and effective 
methods of accessing complex polycyclic structures, both in nature and in the laboratory, due to 
their utility as a method of rapidly constructing multiple rings in a stereocontrolled fashion.9 In 
nature, these complex transformations are carried out by enzymes with high efficiency, which 
initiate cationic cyclization with excellent stereocontrol and high yield.9,10 Synthetically, 
researchers have been able to mimic these results in both radical and cationic manifolds.9 
One of the most powerful and widely-used methods is the epoxide-initiated cationic 
polyene cyclization (Figure 1).11 However, despite the depth of research in the literature, there has 
been little exploration into methods of directly accessing C18 and C19 oxygenation (Figure 1.2b, 
below). Our group recently disclosed an approach to epoxide-initiated polycyclizations which 
allows for direct access to these structural motifs in a stereocontrolled fashion (Figure 1.2c).12 We 
envisioned applying this cyclization technology to a convergent synthesis of ceylonamide A. 
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Figure 1.2: Epoxide-initiated polyene cyclizations 
 
1.2.1 Epoxide-initiated cationic polyene cyclizations 
Scheme 1.1: Biosynthetic polyene cyclization by lanosterol synthase 
 
Lanosterol synthase is an oxidosqualene cyclase enzyme that performs an enzymatic 
epoxide-initiated cationic polyene cyclization to form lanosterol, a key intermediate in the 
cholesterol biosynthetic pathway in humans (Scheme 1.1).13 The mechanism of this biosynthetic 
transformation begins with a pre-organization of the substrate (1.11) into the desired chair-boat-
chair reactive conformation; protonation of the epoxide then leads to the formation of the A-ring, 
and a subsequent stepwise cascade of ring-forming reactions via alkene attack on the intermediate 
carbocations assembles the polycyclic core.13, 14 Subsequent hydride and methyl shifts form the 
final lanosterol product (1.12). While the advantage of active site pre-organization is, of course, 
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one factor that cannot readily be replicated in the laboratory, these epoxide-initiated 
transformations have nevertheless been successfully utilized for a variety of total 
syntheses.10,11,15,16 
Scheme 1.2: Corey (1997): example of stereoselectivity in internal-epoxide-initiated cyclizations 
 
Much like the biosynthetic pathway, the vast majority of epoxide-initiated polyene 
cyclizations utilize a 2,3-disubstituted epoxide motif, wherein the oxirane is on C3 and C4 
(Scheme 1.2). Stereocontrol is imposed by the configuration of the epoxide, as the most favorable 
reactive conformation will place the epoxide in a pseudo-equatorial orientation, resulting in 
preferential formation of the corresponding product stereochemistry.10,17 Furthermore, internal-
epoxide-initiated cyclizations result in oxygenation at the C3 position. While this is ideal for the 
construction of natural products with that oxygenation pattern, such as the sterols, this complicates 
the issue of how to install oxygenation at the C18 or C19 position – the desired oxygenation pattern 
for the ceylonamides, among others (e.g. steviol, 1.16; neotripterifordin, 1.24; see below). The 
most common strategy used for accessing C19 oxygenation when assembling a polycyclic core 
via epoxide-initiated polyene cyclization is to pre-install oxygenation at the desired position, and 
excise the undesired C3-carbinol formed by the epoxide ring opening.17,18 
Scheme 1.3: Baran’s synthesis of (±)-steviol via epoxide-initiated polyene cyclization 
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Baran and coworkers utilized this strategy in their 2013 synthesis of (±)-steviol (1.16).17 
Their key ring forming step was carried out using a substrate (1.13) which had the desired C19 
oxygenation pre-installed and protected as the benzyl ether (Scheme 1.3). They were able to 
accomplish a terminal-epoxide-initiated bicyclization to access tricycle 1.14 selectively. The 
authors justify their strategy by making the point that, absent any other element to impose 
stereocontrol, cyclizations utilizing terminal epoxides result in preferential C18 oxidation – that 
is, oxygenation on the equatorial methyl group, as demonstrated in van Tamelen and coworkers’ 
1983 synthesis of (±)-aphidicolin (Figure 1.3a), and in Goldsmith and Phillips’s 1969 study of 
terminal-epoxide-initiated bicyclizations (Figure 1.3b).18-21 The preference of the epoxide for a 
pseudo-equatorial orientation resulted in the desired placement of the benzyl ether into the pseudo-
axial position for cyclization, affording the desired C19 oxygenation in tricycle 1.15; however, 
this route subsequently required two steps to remove the undesired C3 oxygenation.  
Figure 1.3: Examples of terminal-epoxide-initiated polyene cyclizations 
 
Scheme 1.4: Corey’s synthesis of neotripterifordin via terminal-epoxide-initiated polyene cyclization 
 
Similarly, in their 1997 synthesis of neotripterifordin (1.24), Corey and coworkers also 
elected to pre-install the C19 oxygenation on their cyclization substrate (1.21); however, in 
contrast to Baran’s strategy towards (±)-steviol, they elected to utilize a terminal epoxide as their 
6 
 
initiating group (Scheme 1.4), and were able to accomplish this cyclization to afford tricycle 1.22 
an 89% yield, much higher than the typical yields for similar polyene cyclizations.11,18 The authors 
attribute the efficiency of this cyclization to bidentate coordination of the TiCl4 by the proximal 
epoxy and ethereal oxygens, which they believed minimized side reactivity.18 As with most 
terminal-epoxide-initiated cyclizations (Figure 1.3, above), this reaction resulted in epoxide ring 
opening to give the equatorial (C18) hydroxymethyl group, hence why it was necessary to pre-
install the C19 oxygen as the benzylic ether. This undesired C18 oxygenation required two steps 
to excise to afford 1.23, which was then elaborated to the natural product (1.24). 
1.2.2 Chlorine-atom-controlled, terminal-epoxide-initiated polyene cyclizations 
Figure 1.4: Vanderwal (2019): stereoselective terminal-epoxide-initiated bicyclizations via a proximal 
chloride auxiliary 
 
Recently, our group reported a total synthesis of the lissoclimide natural products 
haterumaimides J and K, in which one of the key steps was a highly diastereoselective terminal-
epoxide-initiated polyene cyclization, wherein a proximal chloride served as a key element of 
stereocontrol (Figure 1.4).12 These results were obtained by coworker Sharon Michalak, who 
carried out a number of cyclization studies on these systems.22 When substrate 1.25 was subjected 
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to cyclization conditions, bicycle 1.26 was obtained with >20:1 dr favoring carbinol formation at 
C18 (Figure 1.4a). In contrast, the des-chlorinated analogue of 1.25 (not shown) was found to 
afford a 5:1 dr favoring C18 oxygenation.22 We hypothesized that the C2 chloride preferred to sit 
pseudo-equatorial position in the reactive conformation (IM-1.25), thus dictating the orientation 
of the epoxide during the cyclization. In addition, Sharon Michalak prepared the anti diastereomer 
of the cyclization substrate (1.29), and subjected it to similar cyclization conditions (Figure 1.4b). 
This afforded bicycle 1.30 in an 11:1 dr favoring the C19 carbinol. In light of this, we believed 
that this cyclization chemistry could be applied to the synthesis of ceylonamide A to furnish the 
desired C19 oxygenation without the necessity of pre-installing it (Scheme 1.5, below). 
Scheme 1.5: Proposed cyclization strategy towards the synthesis of ceylonamide A 
 
1.3 Furans as terminating groups in cationic polyene cyclizations 
In Scheme 1.5 (above), proposed substrate 1.31 contains a 2,3-disubstituted furan as the 
terminating group for the cyclization. Given that the D ring of the ceylonamides is a pyrrolidine, 
the ideal strategy would presumably be to use a pyrrolidinone, rather than a furan. However, there 
have been no reports in the literature of the use of nitrogenous heterocycles as terminating groups 
for cationic polyene cyclizations. On the other hand, furan-terminated cationic cyclizations have 
been established as useful terminating groups for these reactions, and can be converted to the 
desired pyrrolidine.23-25 Notably, Tanis and coworkers published a series of studies on the use of 
furans as terminating groups.24-27 Unfortunately, in all of the reported cases, cyclization took place 
with nucleophilic addition from the 2 or 3 position of the furan. Furthermore, there are no literature 
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reports of cationic polyene cyclizations onto the 4 position of a furan; indeed, one report by Tanis 
suggests that cyclization onto a 3-substituted furan occurs preferentially to the 2-position over the 
4-position (Scheme 1.6, below).24 Nevertheless, we propose that installation of a silyl group at the 
2 position of the furan (C16), as shown in cyclization substrate 1.31 (Scheme 1.5), would prevent 
bond formation at the 2 position, because of the steric bulk of the silyl group and because addition 
at the 4 position would allow the ring to re-aromatize by deprotonation.  
We also elected to utilize a terminating furan because tetracycle 1.36 (Figure 1.5) is a 
known natural product that could presumably be accessed from cyclization product 1.32 in a few 
steps and thus could be used to confirm that we achieved our desired stereochemistry from the key 
cyclization step.1 
Scheme 1.6: Tanis (1983): cyclizations of 3-substituted furans 
 
 
Figure 1.5: Furanyl diterpene 1.36 
 
1.4. Conclusion 
Polyene cyclizations are well-established as useful and powerful methods for rapidly 
assembling polycyclic natural product cores. In particular, the recently-reported chlorine-atom-
controlled cyclization methodology by my coworkers in the Vanderwal group represents a useful 
extension of the field, specifically for the installation of C18 and C19 oxygenation. We felt that a 
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potential application of this technology would be the construction of the tetracyclic core of 
ceylonamide A, wherein the desired C19 oxygenation could be directly accessed from the initiating 
epoxide, without the necessity of pre-installing an oxygen functionality prior to cyclization.  
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CHAPTER 2: Efforts Towards the Synthesis of Ceylonamide A via a 
Stereocontrolled Cationic Polyene Cyclization 
 
 
2.1 Introduction 
 As established in Chapter 1, we hoped to utilize the chloride-controlled epoxide-initiated 
polyene cyclization technology as our key step, in order to achieve the formation of a tetracycle 
such as compound 2.2 (Scheme 2.1). We believed that this could be elaborated to the natural 
product ceylonamide A (2.1) by a few functional group manipulations. We imagined that 
cyclization substrate 2.4 could be accessed via B-alkyl Suzuki between known vinyl iodide 2.6 
and alkyl iodide 2.8. Alkyl iodide 2.8 could, in turn, be accessed from a copper-catalyzed allylic 
substitution between allylic acetate 2.9 and chloromethyl furan 2.10.1-3 This synthetic route was 
chosen because it involves the assembly of a few key fragments, each representing one terpene 
fragment, and whose structures are either known or whose synthesis could be achieved by well-
precedented transformations. 
Scheme 2.1: Retrosynthetic analysis of ceylonamide A 
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2.2 Synthesis of Tricyclization Substrate 
2.2.1 Allylic substitution 
Our plan to carry out the allylic substitution of acetate 2.9 with the Grignard reagent derived 
from chloromethyl furan 2.10 was inspired by the work of Tanis and coworkers, who have 
disclosed in multiple reports the preparation of chloromethyl furan 2.10, from which was prepared 
the corresponding Grignard reagent for the copper-catalyzed substitution of allylic electrophiles 
(Scheme 2.2).1, 4 
Scheme 2.2. Tanis (1984): precedent for allylic substitution with 3-furylmethylmagnesium chloride as 
nucleophile 
 
To that end, we elected to synthesize known trimethylsilylated chloromethyl furan 2.10. 
Rather than the allylic halides utilized by Tanis and coworkers in their study, we elected to utilize 
allylic acetate 2.9 as the electrophilic partner. While the regioselectivity of substitution with allylic 
acetates can be easily tuned to favor the desired α-substitution, allylic halides can often have a 
preference for undesired γ-substitution, which has been attributed to the higher reactivity of the 
allylic halides relative to the analogous acetate.2 
Our synthetic efforts commenced with the preparation of the allylic acetate (Scheme 2.3). 
While we initially considered a Horner–Wadsworth–Emmons olefination route, this was set aside 
in favor of a highly E-selective zirconocene-catalyzed carboalumination. At lower temperatures, 
and in the absence of any potential coordinating groups, these carboaluminations have shown 
complete selectivity for the E product, and generally predictable regiochemistry.5-8   
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Scheme 2.3: Synthesis of allylic acetate 2.9 
 
Known silyl ether 2.15 (Scheme 2.3), prepared from commercially available but-3-yn-1-ol 
(2.14), was then subjected to zirconocene-catalyzed carboalumination followed by addition to 
ethyl chloroformate to form α,β-unsaturated ester 2.16. This ester was then readily reduced to 
allylic alcohol 2.17 by treatment with excess DIBAL-H. Acetylation with acetic anhydride and 
catalytic DMAP also proceeded cleanly and in high yield to afford 2.9. With this electrophile in 
hand, we then began our investigations into the preparation of the Grignard precursor. 
Scheme 2.4: Synthesis of silylated chloromethylfuran 2.10 
 
We first elected to synthesize silylated chloromethyl furan 2.10, where the 2-position is 
substituted with a trimethylsilyl group. Following the route reported by Tanis (Scheme 2.4),1,4 
commercially-available 3-furoic acid 2.12 was ortho-functionalized to afford silylated furoic acid 
2.18. Subsequent LAH reduction afforded alcohol 2.19, and allylic chlorination gave chloromethyl 
furan 2.10. Having synthesized the required fragments, we then began our attempts to effect the 
copper-catalyzed allylic substitution reaction (Scheme 2.5). 
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Scheme 2.5: First attempt at allylic substitution of 2.9 with 2.10 
 
Unfortunately, attempts to carry out this reaction using 2.10, while initially promising, 
were ultimately unproductive. While the desired product (2.21) was isolated successfully a single 
time, serving as a proof of concept, this result was not replicable. Furthermore, efforts to synthesize 
greater amounts of material to investigate and troubleshoot the reaction were hindered by the 
volatility of furanyl alcohol 2.19 and chloromethyl furan 2.10, making them difficult to handle and 
resulting in lower-than-expected yields overall from this route. Furthermore, coworker Sharon 
Michalak experienced difficulties with protodesilylation when using a trimethylsilyl-substituted 
furan, which she resolved by instead utilizing a (t-butyl)dimethylsilyl-substituted furan.9 In light 
of this, we elected to prepare the analogous chloromethyl furan 2.11, which we presumed would 
have a lower volatility, making it easier to handle, and less of a potential source of difficulty later 
in the synthesis. Fortuitously, we found that the synthesis of furanylmethanol 2.24 (Scheme 2.6, 
below) has been reported in the literature, and so we commenced on a synthetic route to prepare 
2.11 as the Grignard precursor.10 
Scheme 2.6: Synthesis of silylated chloromethylfuran 2.11 
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Lithium aluminum hydride reduction of 3-furoic acid (2.12, Scheme 2.6) afforded 3-
furanylmethanol 2.22, which was silylated with (t-butyl)dimethylsilyl chloride to give silyl ether 
2.23. This silyl ether was treated with n-BuLi in HMPA/THF at cryogenic temperature to induce 
a retro-Brook 1,4-shift to afford silylated furyl alcohol 2.24. With this furan, it was found that the 
allylic chlorination could be carried out simply by treating 2.24 with Et3N and mesyl chloride to 
give chloromethyl furan 2.11 in high yield. With this Grignard precursor available via a scalable 
route, we were able to optimize the protocols for both the Grignard reagent preparation and the 
copper-catalyzed substitution reaction. Accordingly, furylmethylmagnesium chloride 2.25 could 
be prepared from chloride 2.11 with high conversion (Scheme 2.7, below), which was then used 
to carry out the allylic substitution reaction with catalytic Li2CuCl4 to afford 2.26 in reproducibly 
good yields.  
Scheme 2.7: Allylic substitution of 2.9 with furylmethyl Grignard 2.25 
 
2.2.2. Preparation of epoxide-containing fragment 2.6 
Scheme 2.8: Towards synthesis of epoxide 2.6 
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With the furanyl fragment (2.26) in hand, we commenced preparation of the epoxide 
coupling fragment 2.6. The synthesis of this known molecule was first developed by Sharon 
Michalak. 11 As shown in Scheme 2.8, lithiated trimethylsilyl acetylene was added to commercial 
(±)-epichlorohydrin (2.27) to afford chlorohydrin 2.29, which underwent epoxide formation under 
basic conditions to give oxirane 2.30. Addition of isopropenyl cuprate to the less substituted 
position of the epoxide afforded alcohol 2.31. Desilylation of this alkyne with potassium carbonate 
in methanol gave terminal alkyne 2.32. This alkyne was then subjected to carboalumination 
followed by iodination to afford vinyl iodide 2.33. Chlorination was carried out by treatment of 
2.33 with triphosgene and pyridine, conditions developed by the Kartika group which minimized 
undesired elimination pathways, to give chloride 2.34.12 
Scheme 2.9: Sharpless dihydroxylation and completion of synthesis of 2.6 
 
Sharpless dihydroxylation with (DHQ)2PHAL ligand selectively oxidized the terminal 
alkene of 2.34 to afford diols (±)-2.35 (undesired diastereomer) and  (±)-2.36 (desired 
diastereomer) as a 1:1.4 mixture of diastereomers.13 This dr is notably lower than the 6:1 syn:anti 
dr previously reported by our group; however, that dihydroxylation had been carried out on 
enantiopure material.11 In our case, the outcome was complicated by the fact that this asymmetric 
dihydroxylation was carried out on racemic material. Based on the empirical mnemonic reported 
by Sharpless and coworkers, the dihydroxylation of (±)-2.34 with (DHQ)2PHAL ligand should 
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afford diols 2.35b and 2.36a as the major products in equal amounts, and 2.35a and 2.36b as the 
minor products in equal amounts; therefore, the expected outcome would be a 1:1 mixture of diols 
2.35 and 2.36.13,14 However, the phthalazine ligands used in the Sharpless asymmetric 
dihydroxylation are chiral molecules, and it is reasonable to presume that (DHQ)2PHAL might not 
exhibit the same facial selectivity with (R)-2.34 as with (S)-2.34 due to the proximal chloride 
stereocenter, which could influence the approach of the sterically bulky ligand. Indeed, Lannou 
and coworkers investigated the dihydroxylation of substrates similar to ours – terminal alkenes 
with stereocenter in the homoallylic position – and found that these ligands did not exhibit the 
same diastereofacial selectivity of between the two enantiomers of a given substrate.15 As we did 
not investigate the enantiomeric ratios of diols 2.35 and 2.36 obtained from the dihydroxylation of 
2.34, it is not known which enantiomer of 2.34 represents the matched case versus the mis-matched 
case for the facial selectivity of the DHQ and DHQD ligands. Our decision to utilize (DHQ)2PHAL 
was informed by empirical results obtained by coworker Sharon Michalak from her preliminary 
investigations into the dihydroxylation of 2.34. These diastereomers are separable by silica gel 
column chromatography, allowing desired diol 2.36 to be isolated; therefore, we considered this 
outcome acceptable for an initial synthetic attempt. Diol 2.36 was carried through epoxidation 
conditions to afford the desired coupling fragment 2.6. 
Scheme 2.10: Efforts toward a simplified synthetic route to (±)-2.6 
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This route is fairly lengthy, and as we were not yet interested in preparing enantiopure 
material, its major advantage of starting from chiral pool material was rendered inconsequential. 
We undertook some preliminary investigation into an alternative and much shorter route to 
advance racemic material more quickly. We considered a disconnection at the site of the secondary 
chloride. The planned route was to carry out nucleophilic addition to known aldehyde 2.38 to form 
alcohol 2.33 (Scheme 2.10).16-19 From here, this would simply converge with the established route 
(Scheme 2.8, above). Thus aldehyde 2.38 was prepared via carboalumination of commercially 
available but-3-yn-1-ol (2.14) followed by iododealumination to afford homoallylic alcohol 2.37, 
which was then oxidized with Dess–Martin periodinane to afford the desired aldehyde (2.38). We 
found that this species was unstable to purification attempts and prone to decomposition in air and 
in solution at room temperature; thus, 2.38 was carried forward without purification. Nucleophilic 
addition of methallylmagnesium chloride to 2.38 afforded the desired alcohol 2.33, but in low, 
inconsistent yields. Attempts to carry out this route on gram scale were complicated by the 
decomposition of the aldehyde, which was exacerbated on larger scale. This rendered the route 
inefficient for its intended purpose of rapidly advancing significant amounts of material; therefore, 
these attempts were abandoned. We nevertheless consider this disconnection worth pursuing if any 
further use is made of epoxide substrate 2.6. One potential route might be the application of the 
Krische group’s iridium-catalyzed asymmetric methallylation of alcohols.20 
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2.2.3 Assembly of tricyclization substrate 
Scheme 2.11: Assembly of cyclization substrate 2.5 
 
With epoxide fragment 2.6 in hand, our attention turned to the assembly of the cyclization 
substrate (Scheme 2.11). The alkyl iodide coupling partner was prepared by deprotection of silyl 
ether 2.26 with catalytic acid to afford alcohol 2.39, which underwent an Appel reaction to afford 
2.40. This alkyl iodide was coupled with epoxide 2.6 via a B-alkyl Suzuki reaction to afford 
cyclization substrate 2.5.  
2.3 Cyclization studies 
2.3 Initial tricyclization attempts 
With this substrate in hand, we attempted to screen conditions in order to effect the desired 
tricyclization reaction. A logical starting point was the conditions previously reported by our group 
for chloride-controlled terminal-epoxide polycyclizations; however, as table 2.1 (below) shows, a 
wide range of conditions were screened in the hopes of effecting this transformation.  
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Table 2.1: Attempts to cyclize substrate 2.5
 
* = also observed product of unknown structure, tentatively considered product of a monocyclization pathway 
Figure 2.1: Products isolated from attempted cyclization reactions of 2.5 
 
While it is difficult to establish any trends from this data, a few commonalities can be 
observed. Complete conversion was favored mostly by temperatures of –78 °C or slightly higher. 
Lewis acid Solvent Temp (°C) Time Full 
conversion? 
Isolated 
products 
excess BF
3
·OEt
2
 CH
2
Cl
2
 –78 30 min No 2.41* 
1.7 equiv. EtAlCl
2
, cat DTBP CH
2
Cl
2
 –78 → –70 30 min Yes 2.41* 
3.0 equiv. Et
2
AlCl CH
2
Cl
2
 –78 1 h No 2.41* 
2.0 equiv. MeAlCl
2
 CH
2
Cl
2
 –78 1 h No 2.5 
1.2 equiv. TiCl
4
 CH
2
Cl
2
 –94 30 min No 2.5 
excess TiCl
4
 CH
2
Cl
2
 –78 30 min Yes 2.42, 2.43 
excess Ti(Oi-Pr)Cl
3
 CH
2
Cl
2
 –78 45 min Yes * 
3.0 equiv. Ti(Oi-Pr)
2
Cl
2
 CH
2
Cl
2
 –78 → –10 5 h Yes 2.41, 2.42* 
3.0 eq FeCl
3
·H
2
O CH
2
Cl
2
 rt 30 min Yes 2.41* 
3.0 eq FeCl
3
 CH
2
Cl
2
 0 → rt 30 min Yes decomp. 
2.0 eq AlCl
3
 CH
2
Cl
2
 –78 1 h Yes * 
1.5 eq Sc(OTf)
3
 CH
2
Cl
2
 –78 → rt 14 h Yes 2.42* 
excess SnCl
4
 CH
2
Cl
2
 –78 30 min No * 
24 
 
Furthermore, a few common products were consistently isolated from these reactions. One of the 
most common was aldehyde 2.41, likely formed as a result of a Meinwald rearrangement of the 
terminal epoxide.21 Another major product isolated, a putative monocyclization product whose 
structure has not been successfully identified, is perhaps the result of Prins-type cyclization of this 
aldehyde (2.41) from further reactivity with trace protons or excess Lewis acid.22 A further isolated 
product was oxabicycle 2.42, presumed to form as a result of the pseudo-axial Lewis acid-
coordinated oxygen of the epoxide being poised to trap the positive charge formed at the C10 
carbon during the cyclization. Another product isolated is 2.43, which is presumed to be the result 
of chloride addition resulting in epoxide ring opening. In addition to the isolable products 
discussed above, most cyclization attempts resulted in the formation of additional, minor products, 
which were observed by TLC but could never be isolated. The material either decomposed or was 
too small in amount to be observed. 
2.3.2 Cyclization control studies 
As we were unable to observe any of the desired cyclization product, our focus turned to 
the possibility that the substrate itself was incapable of cyclization. To investigate this, we carried 
out control studies with a variety of substrates to uncover the confounding factors. We identified 
three possible issues to examine. First, my coworker Sharon Michalak found in her own cyclization 
studies that the chlorinated cyclization substrates tended to have a decreased rate of reaction 
compared to their des-chlorinated analogues; therefore, we would examine the des-chlorinated 
analogue of our tricyclization substrate 2.5.9 Additionally, when comparing this failed chlorine-
atom-controlled cyclization with those which have proven succesful,11 the key differences are the 
identity of the terminating group and the attempted formation of a third ring. To investigate these 
factors, we prepared substrates 2.44, 2.45, and 2.46, respectively.  
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Figure 2.2: Substrates for cyclization control studies 
 
2.3.3. Des-chlorinated tricyclization substrate 2.44 
In the interest of efficiency, we elected to prepare des-chlorinated analogue 2.44 by de-
chlorination of substrate 2.5 (Scheme 2.12). This was accomplished by treating 2.5 with excess 
tributyltin hydride and AIBN, cleanly affording des-chloride substrate 2.44. This was then 
subjected to similar cyclization conditions as the previous substrate (Table 2.2). 
Scheme 2.12: De-chlorination of cyclization substrate 2.5 
 
Table 2.2. Cyclization of des-chlorinated analogue of tricyclization substrate. 
 
Conditions Solvent Temp (°C) Time Isolated products 
4.0 eq Ti(Oi-Pr)Cl3 CH2Cl2 –78 → –60 1 h 2.48, 2.49* 
3.0 eq EtAlCl2 CH2Cl2 –78 → –60 1 h 2.50 
3.0 BF3·OEt2 CH2Cl2 –78 → –60 1 h 2.48, 2.49, rsm 
3.0 TiCl4, PhMe/CH2Cl2 –78 → –60 1 h 2.49* 
3.0 eq EtAlCl2 PhMe/CH2Cl2 –78 → –60 1 h 2.50 
3.0 BF3·OEt2 PhMe/CH2Cl2 –78 → –60 1 h 2.48, 2.49 
* = also observed non-polar isolated product, structure unassigned 
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Figure 2.3: Products isolated from attempted cyclization reactions of 2.44 
 
Unfortunately, none of the desired tetracycle 2.47 was ever observed as a product of these 
cyclizations (Table 2.2). Three major products were isolated and were identified as aldehyde 2.48, 
oxabicycle 2.49, and dichloride 2.50 both presumably formed through similar reactivity as in the 
case of substrate 2.5. In addition, a major non-polar product, thought to be the product of 
monocyclization, was also isolated. The results of this attempted cyclization indicated that the 
presence of the chloride is not the only confounding factor in this cyclization. 
2.3.4. Alteration of terminating furan 
In order to investigate the effect of the terminating furan, we attempted a tricyclization 
wherein the terminating group was the 2,5-substituted furan motif found in the cyclization 
substrates that previously led to successful outcomes.11 Synthesis of substrate 2.45 (Scheme 2.13, 
below) was accomplished by coupling known vinyl iodide 2.51 with known alkyl iodide 2.52 via 
a B-alkyl Suzuki to afford silyl ether 2.53. Treatment with catalytic acid, unlike 2,3-disubstituted 
furan 2.26, resulted in partial protodesilylation at C16 in addition to formation of the desired 
product, alcohol 2.54. Treatment with TBAF prevented protodesilylation, but resulted in a lower 
yield. Iodination of 2.54 afforded alkyl iodide 2.55, which was then subjected to B-alkyl Suzuki 
conditions with 2.6 to give cyclization substrate 2.56. 
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 Scheme 2.13: Synthesis of tricyclization substrate 2.56 
 
This substrate was subjected to cyclization conditions; however, once again, formation of 
the desired tetracycle was not observed. In this case, a much smaller screen of conditions was 
performed. The fact that the previously optimized conditions for analogous bicyclization – EtAlCl2 
in dichloromethane – were not successful served as a strong indication that this cyclization was 
not going to be fruitful. We presume the presence of the additional double bond insulates the 
epoxide from the electron-rich furan, such that this known terminating group was not able to induce 
this cyclization. In this case, the major isolated product was the aldehyde, indicating that the 
cyclization is once again not able to outcompete undesired reactivity pathways. 
Scheme 2.14: Attempted tricyclization of substrate 2.56 
 
2.3.5. Bicyclization control study 
Finally, to investigate the suitability of the 2,3-substituted furan moiety as a terminating 
group for the cyclization, we decided to test a bicyclization analogue of our initial cyclization 
substrate, again utilizing the 2,3-disubstituted furan terminating group. Since it is known that this 
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exact reaction works with the 2,5-disubstitued furan, this would be a crucial result to confirm 
whether the terminating group was a confounding factor. As discussed in chapter 1, cyclization 
onto the 4-position of the furan is poorly precedented, so it follows that it may be one of the key 
issues.  
Scheme 2.15: Attempted synthesis of bicyclization substrate 2.46 
 
Initially, we planned to prepare bicyclization substrate 2.46 via a B-alkyl Suzuki reaction 
between alkyl iodide 2.60 and vinyl iodide 2.6 (Scheme 2.15). Chloromethyl furan 2.11 was 
homologated by formation of the organozinc followed by addition to formaldehyde to give alcohol 
2.59. This alcohol was then subjected an Appel reaction to afford alkyl iodide 2.60. The B-alkyl 
Suzuki coupling of 2.60 and 2.6 was then attempted; however, we were surprised to find that we 
did not observe formation of the expected product. Suspecting that the issue lay with the initial in 
situ formation of the alkyl borane via lithiation, we carried out a few NMR experiments wherein 
lithiation of the alkyl iodide was carried out in ethereal solvent and then quenched with deuterated 
methanol. Instead of the expected deuteration at the former site of the iodine atom, we instead 
observed a shift in the silyl peaks, and a minor peak indicating the presence of a proton at the 2-
position, presumably as a result of quenching by an adventitious proton source. Although no 
products were isolated from these experiments, we presumed that these results might indicate an 
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undesired 1,4-silyl migration. As such, we elected to pursue a different approach to the formation 
of this substrate. 
Scheme 2.16: Synthesis of bicyclization substrate 2.46 
 
Rather than relying on in situ formation of the alkyl borane via lithiation of an alkyl iodide, 
we planned instead to carry out an in-situ hydroboration of an alkene (Scheme 2.16). Starting from 
furanyl alcohol 2.24, oxidation with Dess-Martin periodinane cleanly afforded aldehyde 2.61, 
which was then subjected to a Wittig olefination to afford vinyl furan 2.62. Having confirmed via 
a hydroboration-oxidation experiment that 2.62 would form the desired alkyl borane on treatment 
with 9-BBN, vinyl furan 2.62 was subjected to a B-alkyl Suzuki reaction to couple with 2.6, 
affording bicyclization substrate 2.46.  
Scheme 2.17: Attempted cyclization of 2.46 
 
On subjecting 2.46 to Lewis-acidic cyclization conditions (Scheme 2.17), formation of the 
desired cyclization product was not observed. Since this substrate was otherwise identical to one 
of the substrates known to be competent for cyclization, the 2,3-furan moiety is clearly not a 
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sufficiently active terminating group for this system.11 As discussed above, cyclizations to the 4 
position of furans is, to our knowledge, unknown in the literature. We have concluded that the 
furanyl moiety required to synthesize the ceylonamides via this tricyclization method is simply not 
suitable as a terminating group. 
2.4. Conclusion 
Synthesis of the desired tricyclization substrate (2.5) towards the synthesis of ceylonamide 
A was achieved in a relatively straightforward manner; however, attempts to carry out the key 
cyclization step were not fruitful. The desired product was not observed under a range of conditions 
which are well-precedented in the body of literature on cationic epoxide-initiated polycyclizations. 
To better understand this result, we carried out a number of control studies, the results of which 
point to two main confounding factors: the difficulty of accomplishing a tricyclization relative to 
a bicyclization, and the unsuitability of the furanyl terminating group needed for this synthesis. 
While there are a number of other control studies that would be worth considering, such as 
analogues utilizing the syn-diastereomer of the chloroepoxide fragment, or adjustments to the silyl 
group on the furan, the results obtained from the control studies are sufficiently damning for the 
feasibility of this synthetic route. As a result, serious reworking would need to be undertaken in 
order to carry out this synthesis, especially if the synthetic route were to rely on the chloride-
controlled cyclization method. 
The chloride-controlled polyene cyclization technology can be imagined to be applicable 
to the wide range of C18 and C19-oxygenated terpene and terpenoid natural products; however, 
the results of this project demonstrate that the key groups must be carefully considered, as this 
chemistry is not applicable in all cases. Further investigations are required in order to expand the 
generality and applicability of this exciting method of epoxide-initiated polyene cyclization. 
31 
 
2.5. Experimental Procedures 
Unless otherwise noted, all reactions were performed under an atmosphere of argon using 
flame-dried or oven-dried glassware and Teflon® coated stir bars. Anhydrous solvents were 
prepared by passage through columns of activated alumina. All amine bases were distilled from 
calcium hydride prior to use except for s-collidine and 2,6-di-tert-butylpyridine, which was used 
as received. HMPA was distilled from CaH2 and stored over molecular sieves. DCE specified as 
“dry” and TMSCl were distilled over CaH2 prior to use. Anhydrous solvents were prepared by 
passage through a column of activated alumina and a column packed with Q5 reactant, a supported 
copper catalyst for scavenging oxygen, under a positive pressure of argon. All other reagents were 
used as received or prepared according to literature procedures, unless otherwise noted. Unless 
otherwise specified, reaction progress was monitored by thin-layer chromatography (TLC) 
performed on Merck silica gel 60 F254 glass-backed TLC plates visualized with UV (254 nm) and 
potassium permanganate (KMnO4)/heat or p-anisaldehyde/heat as developing agents. Column 
chromatography was performed using EMD Millipore 60 Å (0.040–0.063 mm) mesh silica gel 
(SiO2), and eluent systems are reported as %v/v. 
1H NMR spectra were recorded at 298 K on Bruker GN500 (499 MHz), Bruker CRYO500 
(500 MHz), and Bruker AVANCE600 (600 MHz) spectrometers. 13C NMR spectra were recorded 
at 298 K on Bruker CRYO500 (125 MHz) and Bruker AVANCE600 (151 MHz) spectrometers. 
Chemical shifts are reported in ppm, referenced from CDCl3 residual peaks at 7.26 ppm (
1H NMR) 
and 77.16 ppm (13C). Coupling constants (J) are reported in Hz. Peak multiplicities are reported 
as ap (apparent), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad). High 
resolution mass spectra (HRMS) were recorded on a Waters LCT Premier spectrometer using ESI-
TOF. Low resolution mass spectra (LRMS) were recorded on a Waters LCT Premier spectrometer 
using ESI-TOF. 
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(but-3-yn-1-yloxy)(tert-butyl)dimethylsilane 2.15. Imidazole (4.95 g, 72.7 mmol), TBSCl (4.73 
g, 31.4 mmol), and DMAP (404 mg, 3.30 mmol) were dissolved in anhydrous DCM (330 mL) and 
cooled to 0 °C with stirring. 3-butyn-1-ol 2.14 (2.5 mL, 33.0 mmol) was added slowly, and the 
reaction was allowed to stir overnight, coming to rt. The reaction was quenched by the addition of 
250 mL sat. aq. NH4Cl and 150 mL brine. The layers were separated, and the aqueous layer was 
extracted with DCM (4 × 50 mL). The combined organic extracts were dried over MgSO4. Solvent 
was removed carefully under vacuum due to the high volatility of the product. The crude residue 
was purified on a short plug of silica (2% EtOAc:hexanes) to afford 2.15 as a clear oil (4.18 g, 
72%). 1H NMR (500 MHz, CDCl3) δ 3.74 (t, J = 7.1 Hz, 1H), 2.40 (td, J = 7.1, 2.7 Hz, 2H), 1.96 
(t, J = 2.6 Hz, 1H), 0.90 (s, 9H), 0.08 (s, 6H). Spectral data matched those previously reported.23 
 
Ethyl (E)-5-((tert-butyldimethylsilyl)oxy)-3-methylpent-2-enoate (2.16). Cp2ZrCl2 (3.89 g, 
13.3 mmol) was added to a 250 mL round-bottomed flask. The vessel was evacuated and backfilled 
with argon, and to it was added 13 mL DCE plus 20 mL dry DCE. The mixture was cooled in a 
salt-ice bath to –5 °C, and AlMe3 (10.2 mL, 106 mmol) was added slowly. The reaction mixture 
was stirred for 5 min in the ice bath (kept between –5 °C and 0 °C) and then 10 min at rt. The 
reaction vessel was then returned to the ice bath, approx. 20 μL of DI water was added, and the 
reaction mixture was then stirred at rt for another 15 min. Then the flask was cooled to –20 °C, 
and a solution of alkyne 2.15 (9.80 g, 53.1 mmol) in 4 mL DCE was added slowly, followed by 6 
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mL DCE. The reaction mixture was then slowly warmed to rt over 3 h, and allowed to stir overnight 
at rt. The flask was then cooled to –25 °C and ethyl chloroformate (7.62 mL, 79.7 mmol) was 
added slowly. The reaction mixture was allowed to warm to room temperature over 2.5 h and then 
stirred at rt for a further 1 h. The flask was cooled again to –20 °C and the reaction was quenched 
by the slow addition of sat. aq. citric acid, with vigorous stirring, until the bubbling was no longer 
vigorous, and warmed to rt. Then the reaction mixture was diluted with sat. aq. citric acid and sat. 
aq. potassium sodium tartrate until two clear layers formed. This mixture was then diluted with 
Et2O and the layers were separated. The aqueous layer was extracted 3 times with Et2O. The 
combined organic layers were washed successively with water and brine, dried over MgSO4, 
filtered, and concentrated under vacuum. The crude residue was subjected to column 
chromatography (2% EtOAc:hexanes) to afford 2.16 (6.04, 42%). 1H NMR (500 MHz, CDCl3) δ 
5.68 (d, J = 1.1 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.74 (t, J = 6.7 Hz, 2H), 2.34 (t, J = 6.7 Hz, 2H), 
2.18 (d, J = 1.2 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H), 0.88 (s, 9H), 0.04 (m, 6H). The spectral data 
matched those previously reported.24 
 
(E)-5-((tert-butyldimethylsilyl)oxy)-3-methylpent-2-en-1-ol (2.17). Ester 2.16 (1.17 g, 4.31 
mmol) was dissolved in anhydrous toluene and cooled to –20 °C. A 1.0 M solution of DIBAL-H 
in hexanes (10.3 mL, 10.3 mmol) was added slowly. The reaction mixture was stirred for 30 min 
at rt, then cooled to –20 °C and diluted with additional toluene. The reaction was quenched by the 
slow addition of 0.04 mL water, followed by 0.04 mL of 15% w/w aqueous NaOH, and then 1 mL 
of water. The mixture was stirred for 30 min, warming to rt. Solid MgSO4 was added, and the 
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mixture was stirred for an additional 15 min at rt, then filtered over celite. Solvent was removed 
under vacuum to afford 2.17, which was carried forward without purification (890 mg, 90%). 1H 
NMR (499 MHz, CDCl3) δ 5.44 (tdd, J = 6.9, 2.4, 1.2 Hz, 1H), 4.15 (t, J = 6.2 Hz, 2H), 3.70 (t, J 
= 7.0 Hz, 2H), 2.24 (t, J = 7.0 Hz, 2H), 1.70 (s, 3H), 1.55 (s, 1H), 1.11 (t, J = 5.5 Hz, 1H), 0.89 (s, 
9H), 0.05 (s, 6H). The spectral data matched those previously reported.25 
 
(E)-5-((tert-butyldimethylsilyl)oxy)-3-methylpent-2-en-1-yl acetate (2.9). Allylic alcohol 2.17 
(889 mg, 3.86 mmol) and DMAP (9.4 mg, 0.077 mmol) were dissolved in anhydrous DCM (8 
mL). The flask was cooled to 0 °C, and Et3N (0.81 mL, 5.79 mmol) and Ac2O (0.44 mL, 4.63 
mmol) were added. The reaction mixture was stirred at 0 °C for 30 min. The reaction was quenched 
by the addition of water (10 mL). The layers were separated and the aqueous layer was extracted 
3 times with DCM. The combined organic extracts were dried over MgSO4, filtered, and 
concentrated under vacuum. The crude residue was purified by column chromatography (5% 
EtOAc:hexanes) to afford 2.9 (928 mg, 93%). 1H NMR (500 MHz, CDCl3) δ 5.37 (ddd, J = 8.4, 
5.9, 1.3 Hz, 1H), 4.58 (d, J = 7.2 Hz, 2H), 3.70 (t, J = 6.8 Hz, 2H), 2.25 (t, J = 6.8 Hz, 2H), 2.05 
(s, 3H), 1.72 (s, 3H), 0.88 (s, 9H), 0.04 (s, 6H); 13C (150 MHz, CDCl3) δ 171.24, 139.63, 120.25, 
61.94, 61.38, 42.89, 26.05, 21.18, 18.45, 16.96, 5.19.  
 
2-(trimethylsilyl)furan-3-carboxylic acid (2.18). i-Pr2NH (7.50 mL, 53.5 mmol) was dissolved 
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in anhydrous THF (27 mL) and cooled to –10 °C. A 2.5 M solution of n-BuLi in hexanes (21.4 
mL, 53.5 mmol) was added slowly, and the solution stirred at –10 °C for 30 min. The flask was 
then cooled to –78 °C, and a solution of 3-furoic acid 2.12 (3.00 g, 26.8 mmol) in 16 mL anhydrous 
THF was added slowly. The reaction mixture was stirred at –78 °C for 30 min, then distilled 
TMSCl (11.9 mL, 93.7 mmol) was added. The flask was then allowed to come to rt, with stirring, 
over 1 h. The reaction was quenched by the addition of 15 mL of water and 24 mL of 2 N HCl. 
This mixture was stirred for 20 min at rt, then diluted with 25 mL water. The layers were separated, 
and the aqueous layer was extracted with Et2O (3 x 25 mL). The combined organic extracts were 
washed with brine, dried over MgSO4, filtered, and concentrated under vacuum. The crude residue 
was purified by column chromatography to afford 2.18 as an off-white solid (1.97 g, 40%). 1H 
NMR (500 MHz, CDCl3) δ 7.59 (d, J = 1.7 Hz, 1H), 6.79 (d, J = 1.7 Hz, 1H), 0.37 (s, 9H). The 
spectral data matched those previously reported.26  
 
(2-(trimethylsilyl)furan-3-yl)methanol (2.19). To a stirring suspension of LAH (134 mg, 3.53 
mmol) in anhydrous Et2O (4.1 mL) in a fame-dried flask equipped with magnetic stirring and 
cooled to 0 °C was added furancarboxylic acid 2.18 (500 mg, 2.71 mmol) as a 1.25 M solution in 
anhydrous Et2O, under argon. The reaction was then stirred for 1.5 h at rt, then cooled to 0 °C and 
diluted with Et2O. Water (0.13 mL) was added slowly, followed by 15% w/w aqueous NaOH (0.13 
mL) and water (0.4 mL). The mixture was stirred vigorously for 30 min at rt. Solid MgSO4 was 
added, and the mixture was stirred for an additional 15 min at rt, and then filtered over celite, 
washing with Et2O. The product solution was concentrated under vacuum to afford 2.19, which 
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was carried forward without purification (378 mg, 82%). 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J 
= 1.5 Hz, 1H), 6.45 (d, J = 1.6 Hz, 1H), 4.59 (s, 2H), 1.51 (br, 1H), 0.31 (s, 9H). The spectral data 
matched those previously reported.26 
 
(3-(chloromethyl)furan-2-yl)trimethylsilane (2.10). LiCl (126 mg, 2.97 mmol) was placed into 
a round-bottom flask, which was evacuated and backfilled with argon, and the LiCl was then flame 
dried under vacuum. Anhydrous DMF (3.15 mL) and furan methanol 2.19 (253 mg, 1.48 mmol) 
were added to the flask at rt, followed by s-collidine (0.39 mL, 2.97 mmol). The solution was 
cooled to 0 °C and MsCl (0.17 mL, 2.22 mmol) was added slowly. The reaction was stirred for 30 
min at 0 °C, then allowed to come to rt and stirred for 4.5 h. The reaction was quenched by the 
addition of 10 mL water and 10 mL Et2O. The layers were separated, and the aqueous layer was 
extracted with Et2O (3 × 5 mL). The combined organic extracts were washed with 3 x 8 mL sat. 
aq. CuSO4, 8 mL water, and 8 mL brine. The combined aqueous washes were then extracted with 
10 mL Et2O. The combined organic extracts were dried over MgSO4, filtered, and concentrated 
under vacuum. The crude residue was purified by column chromatography with pH 7 silica (100% 
hexanes) to afford 2.10 as a red oil (160 mg, 57%). 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 1.7 
Hz, 1H), 6.44 (d, J = 1.7 Hz, 1H), 0.34 (s, 9H); The spectral data matched those previously 
reported.1 
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(E)-tert-butyldimethyl((3-methyl-6-(2-(trimethylsilyl)furan-3-yl)hex-3-en-1-yl)oxy)silane 
(2.21). Grignard 2.20 was prepared as follows: metallic magnesium was crushed with a mortar and 
pestle, then 400 mg were transferred to a vial, which was then evacuated and backfilled. The Mg 
was activated by flame drying under vacuum, and then by addition of 1,2-dibromoethane and a 
drop of a concentrated solution of I2 in anhydrous THF. To the activated magnesium in THF, 
cooled to 0 °C, was added chloride 2.10 (86 mg, 0.45 mmol) as a solution in THF, dropwise, to a 
total volume of 0.9 mL. The mixture was stirred 1 h at rt, then allowed to settle over 45 min. The 
supernatant solution titrated to 0.06 M (titration indicator: salicylaldehyde phenylhydrazone). To 
a solution of acetate 2.9 (5 mg, 0.014 mmol) in THF (0.10 mL) was added a drop of 1.0 M 
2Li∙CuCN (~0.01 mL, ~0.01 mmol). The solution was cooled to –30 °C, and Grignard reagent 
2.20 (0.4 mL, 0.024 mmol) was added quickly. The reaction mixture was stirred for 2 h, with the 
cooling bath kept below –15 °C. The reaction was quenched by the addition of sat. aq. NH4Cl. The 
reaction mixture was extracted with Et2O, and the organic extracts were washed with brine, dried 
over MgSO4, filtered and concentrated under vacuum. The crude residue was purified by column 
chromatography (100% hexanes → 5% Et2O:hexanes) to afford 2.21 (3.8 mg, 58%). 1H NMR (500 
MHz, CDCl3) δ 0.04 (s, 6H), 0.28 (s, 9H), 0.89 (s, 9H), 1.60 (s, 3H), 2.18–2.24 (m, 4H), 2.48–2.52 
(m, 2H), 3.66 (t, 2H, J = 7.0 Hz), 5.19–5.22 (m, 1H), 6.28 (d, 1H, J = 1.6 Hz), 7.52 (d, 1H, J = 1.6 
Hz); 13C (150 MHz, CDCl3) δ –5.11, –0.80, 16.60, 18.50, 25.97, 26.11, 29.96, 43.19, 62.56, 
111.40, 125.80, 132.93, 135.49, 146.02, 154.40. 
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Furan-3-ylmethanol (2.22). A solution of furancarboxylic acid 2.12 (10 g, 89 mmol) in 25 mL 
THF was added slowly to a stirring suspension of LAH (6.8 g, 178 mmol) in Et2O (44 mL) at 0 
°C. The reaction was then stirred for 15 min at °C then for 2.5 h at rt. The reaction mixture was 
then diluted with 10 mL Et2O and cooled to 0 °C. DI water (6.8 mL) was added slowly, with 
occasional venting of the flask, followed by 15% w/w aqueous NaOH (6.8 mL), slowly, and finally 
water (21 mL). The mixture was warmed to rt and stirred vigorously for 30 min. The flask was 
then cooled to 0 °C and solid MgSO4 was added in portions. The flask was sonicated briefly (~1 
min) and then stirred vigorously at rt until the slurry was homogenous and stirring freely. The 
mixture was then filtered over celite, washing with Et2O. Solvent was removed under vacuum to 
afford 2.22, which was carried forward without purification (8.1 g, 92%). 1H NMR (500 MHz, 
CDCl3) δ 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.39 (m, 2H), 6.46 – 6.43 (m, 1H), 4.57 (s, 2H), 
1.61 (br, 1H). The spectral data matched those previously reported.27 
 
Tert-butyl(furan-3-ylmethoxy)dimethylsilane (2.23). Imidazole (12.4 g, 182 mmol), TBSCl 
(11.9 g, 78.7 mmol), and DMAP (1.01 g, 8.29 mmol) were dissolved in anhydrous DCM at 0 °C. 
Then furan-3-ylmethanol 2.22 (8.13 g, 82.9 mmol) in 3 mL anhydrous CH2Cl2 was added slowly. 
The reaction mixture was stirred at 0 °C for 15 min, then allowed to come to rt and stirred for 16 
h. An additional 1.01 g DMAP was added and the reaction mixture was stirred for a further 2.5 h. 
The reaction was quenched by the addition of sat. aq. NH4Cl (150 mL) and brine (50 mL) and 
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stirred vigorously until two clear layers were observed. The layers were separated and the aqueous 
layer was diluted with water and extracted with DCM (4 × 100 mL). The combined organic extracts 
were washed with 150 mL of water and 200 mL of brine, dried over MgSO4, filtered, and 
concentrated under vacuum. The crude residue was purified by a short plug of silica (100% 
hexanes → 5% EtOAc:hexanes) to afford 2.23 (15.7 g, 89%). 1H NMR (499 MHz, CDCl3) δ 7.38 
– 7.34 (m, 2H), 6.37 (s, 1H), 4.60 (s, 2H), 0.92 (s, 9H), 0.09 (s, 6H). The spectral data matched 
those previously reported.10 
 
(2-(tert-butyldimethylsilyl)furan-3-yl)methanol (2.24). Silyl ether 2.23 (14.2 g, 67.1 mmol) was 
dissolved in anhydrous THF (200 mL) and the solution was cooled to –78 °C. Distilled HMPA 
(12.9 mL, 73.8 mmol) was added, followed by a 1.6 M solution of n-BuLi in hexanes (46.1 mL, 
73.8 mmol), and the reaction mixture was allowed to stir overnight, coming to rt. The reaction was 
quenched by the addition of 100 mL of sat. aq. NH4Cl to the vigorously-stirring reaction mixture. 
After a white precipitate was observed, the mixture was diluted with water until it just turned clear. 
The layers were separated, and the aqueous layer was extracted with Et2O (4 × 80 mL). The 
combined organic extracts were washed with 200 mL sat. aq. CuSO4, followed by water, dried 
over MgSO4, filtered and concentrated under vacuum. The crude residue was purified by column 
chromatography (5% → 15% EtOAc/hexanes, stepwise gradient) to yield 2.24 as an off-white 
solid (12.3 g, 83%). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 1.2 Hz, 1H), 6.48 (d, J = 1.3 Hz, 
1H), 4.59 (d, J = 5.3 Hz, 2H), 1.34 (t, J = 5.5 Hz, 1H), 0.91 (s, 9H), 0.29 (s, 6H). The spectral data 
matched those previously reported.10 
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tert-butyl(3-(chloromethyl)furan-2-yl)dimethylsilane (2.11). Alcohol 2.24 (1.03 g, 4.85 mmol) 
was dissolved in anhydrous DCM (12 mL) at 0 °C. Et3N (1.35 mL, 9.69 mmol) was added, 
followed by MsCl (0.64 mL, 8.24 mmol), and the reaction mixture stirred overnight at rt. The 
reaction was quenched by the addition of sat. aq. NaHCO3 and the mixture was diluted with Et2O. 
The layers were separated, and the aqueous layer was extracted 3 times with Et2O. The combined 
organic extracts were washed successively with sat. aq. Na2S2O3, water, and brine, dried over 
MgSO4, filtered, and concentrated under vacuum. The crude residue was passed through a plug of 
silica (100% hexanes) to afford 2.11 as a clear oil. 1H NMR (600 MHz, CDCl3) δ 7.59 (d, J = 1.7 
Hz, 1H), 6.46 (d, J = 1.7 Hz, 1H), 4.54 (s, 2H), 0.92 (s, 9H), 0.32 (s, 6H); 13C NMR (151 MHz, 
CDCl3) δ 156.27, 147.05, 132.97, 111.10, 38.29, 26.35, 17.38, -5.81. HRMS (ESI) m / z calcd for 
C11H19ClOSi [M
+] 230.0894, found 230.0893. 
 
(E)-tert-butyl((6-(2-(tert-butyldimethylsilyl)furan-3-yl)-3-methylhex-3-en-1-
yl)oxy)dimethylsilane (2.26). Grignard reagent 2.25 was prepared as follows: Magnesium was 
ground with a mortar and pestle and 1.1 g was placed in a round-bottom flask, which was then 
evacuated and backfilled with argon three times. Anhydrous THF (4 mL) was added to the flask. 
The magnesium was activated by the addition of a crystal of iodine and 0.1 mL dibromoethane, 
followed by sonication and heating. The flask was allowed to cool, and dibromoethane was added 
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dropwise, with periodic sonication followed by heating and cooling, until production of gas was 
observed immediately on addition. The flask was cooled to 0 °C and diluted with a further 1.8 mL 
anhydrous THF. Chloromethylfuran 2.25 was added in a solution of anhydrous THF (5 mL), 
slowly, followed by additional drops of dibromoethane. The reaction mixture was allowed to warm 
to rt over 1 h with stirring, and then stirred for a further 2 h at rt. The supernatant solution titrated 
to 0.06 M (titration indicator: salicylaldehyde phenylhydrazone). Li2CuCl4 was prepared as 
reported in the literature. 
Allylic acetate 2.9 (763 mg, 2.8 mmol) and Li2CuCl4 (0.28 mL, 0.28 mmol, 1.0 M in THF) were 
dissolved in anhydrous THF (6.4 mL). The reaction vessel was cooled to –40 °C, and the solution 
of furylmethylmagnesium chloride 2.25 (9.0 mL, 5.6 mmol) was added over 2.5 min. The reaction 
mixture was stirred for 15 h, coming to rt. The reaction mixture was cooled to 0 °C and quenched 
by the portion-wise addition of sat. aq. NH4Cl (20 mL) and Et2O (12 mL) over 30 min with 
vigorous stirring. Water (5 mL) was added to give two clear layers. The layers were separated and 
the aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic extracts were 
washed successively with 20 mL of water and brine, dried over MgSO4, filtered and concentrated 
under vacuum. The crude residue was purified by column chromatography (100% hexanes → 2% 
EtOAc/hexanes) to afford 2.26 (1.03 g, 90%). 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 1.5 Hz, 
1H), 6.30 (d, J = 1.5 Hz, 1H), 5.21 (dd, J = 7.1, 6.1 Hz, 1H), 3.66 (t, J = 7.0 Hz, 2H), 2.50 (dd, J 
= 9.1, 6.8 Hz, 2H), 2.27 – 2.10 (m, 4H), 1.61 (s, 3H), 0.91 – 0.88 (m, 18H), 0.26 (s, 6H), 0.05 (s, 
J = 2.8 Hz, 6H). 13C NMR (151 MHz, CDCl3) δ 152.89, 146.13, 136.42, 132.75, 125.80, 111.06, 
62.43, 43.07, 29.79, 26.49, 26.03, 26.00, 18.39, 17.64, 16.48, –5.22, –5.49. HRMS (ESI) m / z 
calcd for C23H44O2Si2Na [M+Na]
+ 431.2778, found 431.2771. 
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1-chloro-5-(trimethylsilyl)pent-4-yn-2-ol (28). Trimethylsilyl acetylene 2.28 (9.23 mL, 64.9 
mmol) was dissolved in anhydrous THF (12 mL) and cooled to –78 °C. To this stirring mixture 
was added a 2.5 M solution of n-BuLi in hexanes (26.0 mL, 64.9 mmol) slowly, followed by 
BF3∙OEt2 (8.0 mL, 64.9 mmol), and the reaction mixture was allowed to stir for 10 min. 
Epichlorohydrin 2.27 (3.38 mL, 43.2 mmol) was added as a 3 M solution in anhydrous THF, and 
the reaction  mixture was stirred for 1 h at –78 °C. The reaction vessel was placed in an ice-water 
bath and allowed to come to 0 °C, where it stirred for 30 min. The reaction was quenched by the 
addition of sat. aq. NH4Cl. The layers were separated and the aqueous layer was extracted 3 times 
with Et2O. The combined organic extracts were washed with brine, dried over MgSO4, filtered, 
and concentrated under vacuum. The crude product was carried forward without further 
purification (5.56 g, 67%). The spectral data matched those previously reported.28 
 
Trimethyl(3-(oxiran-2-yl)prop-1-yn-1-yl)silane (2.30). Chlorohydrin 2.29 (5.56 g, 29.2 mmol) 
was dissolved in anhydrous DCM (58 mL) and cooled to 0 °C. Powdered NaOH (4.08 g, 102 
mmol) was added in portions, and the reaction mixture was stirred for 18 h at rt. The reaction was 
quenched by the addition of sat. aq. NH4Cl (75 mL) with vigorous stirring, followed by water (25 
mL). The layers were separated, and the aqueous layer was extracted with 1:1 Et2O:hexanes (3 × 
35 mL). The combined organic extracts were washed successively with 50 mL water and 50 mL 
brine, dried over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified 
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via Kugelrohr distillation to afford 2.30 (3.00 g, 67%). 1H NMR (500 MHz, CDCl3) δ 3.13 – 3.08 
(m, 1H), 2.82 – 2.77 (m, 1H), 2.67 (ddd, J = 9.6, 7.2, 4.4 Hz, 2H), 2.49 (dd, J = 17.5, 5.2 Hz, 1H), 
0.16 (s, 9H). The spectral data matched those previously reported.28 
 
2-methyl-7-(trimethylsilyl)hept-1-en-6-yn-4-ol (2.31). CuI (259 mg, 1.36 mmol) and oxirane 
2.30 (3.00 g, 19.4 mmol) were dissolved in anhydrous THF (35 mL) and cooled to –78 °C. 
Isopropenylmagnesium bromide (81.7 mL, 40.8 mmol, 0.5 M in THF) was added dropwise via 
addition funnel under positive pressure of argon. The reaction mixture was then stirred for 1 h at 
–78 °C, then allowed to come to –30 °C and stirred for 3 hours. Reaction progress was measured 
by 1H NMR analysis of aliquots. When complete conversion was observed, the reaction mixture 
was diluted with 10 mL of Et2O, 20 mL sat. aq. NH4Cl, then another 10 mL of Et2O, and was 
allowed to come to rt with stirring. Water was added until all solids were just dissolved. The layers 
were separated, and the aqueous layer was extracted with Et2O. The combined organic extracts 
were washed with 50 mL brine, dried over MgSO4, filtered, and concentrated under vacuum. The 
crude product was immediately carried forward without purification (3.27 g, 86%).  
 
2-methylhept-1-en-6-yn-4-ol (2.32). Alcohol 2.31 (3.27 g, 16.7 mmol) was dissolved in methanol 
and cooled to 0 °C. K2CO3 (6.92 g, 50.1 mmol) was added. The solution was stirred for 30 min at 
0 °C, and then at rt for 2 h. Then the reaction mixture was concentrated under vacuum to about 
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half its volume then diluted with Et2O. The reaction was quenched by the addition of sat. aq. 
NH4Cl, and the mixture was diluted with water. The aqueous layer was extracted 3 times with 
Et2O. The combined organic extracts were washed with brine, dried over MgSO4, and concentrated 
under vacuum. The crude product 2.32 was carried forward without further purification (1.88 g, 
91%). The spectral data matched those previously reported.11 
 
(E)-1-iodo-2,6-dimethylhepta-1,6-dien-4-ol (2.33). Cp2ZrCl2 (4.07 g, 13.9 mmol) was placed 
into a round-bottom flask, which was evacuated and backfilled with argon. DCE (40 mL) was 
added, and the resulting mixture was cooled to 0 °C. AlMe3 (10.0 mL, 104 mmol) was added 
slowly under positive pressure of argon. The reaction mixture was then warmed to rt and stirred 
for 15 min. The reaction mixture was cooled to 0 °C and three drops of water were added. The 
reaction mixture was stirred 5 min at 0 °C and then 10 min at rt. The reaction mixture was again 
cooled to –20 °C, and alkyne 2.31 (4.32 g, 34.6 mmol) was added, followed by an additional 18 
mL DCE for rinsing. The reaction mixture was stirred at rt for 19h, and then cooled to –78 °C. I2 
(26.5 g, 104.4 mmol) was added slowly as a solution in THF. The reaction mixture was allowed 
to come to –40 °C and then to rt, where it was stirred for 2 h. The flask was cooled, and the reaction 
was quenched by the careful addition of water, followed by 1N HCl. The reaction mixture was 
extracted with hexanes, and the organic extracts washed successively with sat. aq. Na2S2O3, sat. 
aq. citric acid, and water. The organic extracts were dried over MgSO4, filtered, and concentrated 
under vacuum. The crude residue was purified by column chromatography to afford 2.33 (3.91 g, 
40%). 1H NMR (499 MHz, CDCl3) δ 6.02 (s, J = 1.0 Hz, 1H), 4.89 (s, 1H), 4.80 (s, J = 0.8 Hz, 
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1H), 3.92 – 3.85 (m, 1H), 2.39 – 2.35 (m, 2H), 2.20 – 2.09 (m, 2H), 1.89 (d, J = 0.9 Hz, 3H), 1.76 
(s, 3H), 1.71 (br s, 1H). The spectral data matched those previously reported.11 
 
(E)-4-chloro-1-iodo-2,6-dimethylhepta-1,6-diene (2.34). In a heavy-wall glass pressure flask, 
triphosgene (3.09 g, 10.4 mmol) was dissolved in 10 mL anhydrous DCM under positive pressure 
of argon. The vessel was cooled to 0 °C. Alcohol 2.33 (2.77 g, 10.4 mmol) was added as a solution 
in 10 mL anhydrous DCM and 1.68 mL pyridine, slowly, under positive pressure of argon. An 
additional 6 mL anhydrous DCM was used for rinsing. An additional 1.68 mL of pyridine was 
added slowly. The headspace was purged with argon, and then the vessel was sealed with a 
threaded PTFE cap, allowed to come to rt, then heated at 45 °C for 7 h. The reaction mixture was 
cooled to 0 °C, and the reaction was quenched by the slow addition of water, followed by 1 N HCl. 
The mixture was then diluted with 1:1 Et2O:hexanes and stirred for 1 h. The layers were separated 
and the aqueous was layer extracted with 1:1 Et2O:hexanes. The combined organic extracts were 
washed with water and brine, dried over MgSO4, filtered and concentrated under vacuum. The 
crude residue was purified by column chromatography to afford 2.34 (1.55 g, 53%). 1H NMR (500 
MHz, CDCl3) δ 4.90 (s, 1H), 4.83 (s, 1H), 3.97 – 3.88 (m, 1H), 2.48 – 2.31 (m, 3H), 2.24 (dd, J = 
13.8, 8.6 Hz, 1H), 2.07 (t, J = 2.6 Hz, 1H), 2.00 (d, J = 3.8 Hz, 1H), 1.78 (s, 3H). The spectral data 
matched those previously reported.11 
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Diol 2.36. K3Fe(CN)6 (3.79 g, 11.5 mmol), (DHQ)2PHAL (171 mg, 0.22 mmol), K2CO3 (1.88 g, 
13.6 mmol), and MeSO2NH2 (571 mg, 6.00 mmol) were dissolved in 40 mL of a 1:1 mixture pf t-
BuOH:water. The slurry was cooled to 0 °C, and K2OsO2·(H2O)6 (40.5 mg, 0.11 mmol) was added. 
Alkene 2.34 (1.55 g, 5.46 mmol) was added as a solution in 15 mL of the solvent mixture. The 
reaction mixture was then stirred overnight at 0 °C. The reaction was quenched by the addition of 
saturated aqueous NaSO3. The mixture was diluted with EtOAc and stirred for 20 min at 0 °C, 
then 10 min at rt. The layers were separated and the aqueous layer was extracted 3 times with 
EtOAc. The combined organic extracts were dried with MgSO4, filtered, and concentrated under 
vacuum. The crude residue was subjected to column chromatography (25% → 45% 
EtOAc/hexanes, stepwise gradient). The fractions containing the pure product as a mixture of 
diastereomers were collected, and the accumulated material was divided between two samples, 
each of which was re-subjected to the same column conditions, to afford 2.36 as a single 
diastereomer and as a white solid (351 mg, 20%). 1H NMR (500 MHz, CDCl3) δ 6.07 (s, J = 1.0 
Hz, 1H), 4.27 (tdd, J = 8.9, 6.1, 3.1 Hz, 1H), 3.49 (dd, J = 34.3, 11.0 Hz, 2H), 2.65 (qd, J = 14.3, 
7.1 Hz, 2H), 2.37 (br, 2H), 2.02 (dd, J = 15.3, 3.2 Hz, 1H), 1.92 – 1.88 (m, 1H), 1.87 (s, J = 0.9 
Hz, 3H), 1.26 (s, 3H). The spectral data matched those previously reported.11 
Diol 2.35 was also observed as a product of the reaction. The spectral data matched those 
previously reported.11  
 
Epoxide 2.6. Diol 2.36 (367 mg, 1.15 mmol) was dissolved in anhydrous DCM (7.7 mL) and 
cooled to 0 °C. DMAP (105 mg, 0.86 mmol), TsCl (285 mg, 1.5 mmol), and Et3N (0.32 mL, 2.3 
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mmol) were added. The reaction mixture was stirred for 20 min at 0 °C then at rt overnight. The 
reaction mixture was diluted with 8 mL DCM and the reaction was quenched by the addition of 5 
mL sat. aq. NaHCO3. The mixture was poured into a separatory funnel with an additional 20 mL 
sat. aq. NaHCO3 and shaken. The layers were separated, and the aqueous layer was extracted with 
DCM (4 × 5 mL). The combined organic extracts were washed successively with sat. aq. NH4Cl, 
sat. aq. NaHCO3, and brine, dried over MgSO4, filtered and concentrated under vacuum. The crude 
product was taken up in anhydrous MeOH, cooled to 0 °C, and K2CO3 (636 mg, 4.6 mmol) was 
added portion-wise. The reaction mixture was stirred for 2 h, then the volatiles were removed 
under vacuum until the volume was reduced by approximately two-thirds. The solution was then 
diluted with 50 mL of a 1:4 Et2O:hexanes solvent mixture, followed by sat. aq. NH4Cl and water, 
until all solids dissolved. The layers were separated, and the aqueous layer was extracted 3 times 
with the solvent mixture. The combined organic extracts were washed successively with water and 
brine, dried over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified 
by column chromatography (2% → 10% EtOAc/hexanes) to afford 2.6 (247 mg, 71%). 1H NMR 
(600 MHz, CDCl3) δ 6.09 (app s, J = 2.1, 1.0 Hz, 1H), 4.15 (dddd, J = 10.0, 8.3, 5.7, 4.1 Hz, 1H), 
2.74 – 2.62 (m, 4H), 2.11 (ddd, J = 14.4, 4.1, 1.1 Hz, 1H), 1.89 (d, J = 1.0 Hz, 3H), 1.70 (dd, J = 
14.4, 10.2 Hz, 1H), 1.38 (s, 3H). The spectral data matched those previously reported.11 
 
(E)-4-iodo-3-methylbut-3-en-1-ol (2.37). Cp2ZrCl2 (512 mg, 1.75 mmol) was placed into a 
round-bottom flask, which was then evacuated and backfilled with argon. Freshly-distilled DCE 
(8.3 mL) was added. The mixture was stirred until the Cp2ZrCl2 was mostly dissolved, and then 
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cooled to 0 °C. AlMe3 (1.24 mL, 12.9 mmol) was added slowly to the reaction vessel, then a further 
0.20 mL (2.1 mmol) was added slowly to a solution of 1-butyn-1-ol 2.14 (0.38 mL, 5.0 mmol) in 
anhydrous DCM (2.5 mL) pre-cooled to 0 °C. The reaction mixture was stirred at 0 °C for 5 min 
then at rt for 15 min. The reaction vessel was cooled again to 0 °C, and water (2 μL) was added.  
The reaction mixture was stirred at 0 °C for 5 min and then at rt for 15 min. The reaction mixture 
was then cooled to –40 °C, and the solution of 2.14 with AlMe3 was added slowly. The reaction 
mixture was stirred overnight, slowly warming to rt. The reaction mixture was then diluted with 7 
mL anhydrous THF and cooled to –40 °C. I2 (3.54 g, 15.0 mmol) was added as solution in 
anhydrous THF (17 mL) over 1 h via syringe pump addition. The reaction mixture was then stirred 
for 2 h at rt. The reaction mixture was cooled to 0 °C, diluted with 5 mL Et2O, and quenched by 
the slow addition of sat. aq. potassium sodium tartrate, with vigorous stirring, until no more 
evolution of gas was observed. The mixture was then warmed to rt and diluted with water and 
Et2O until two clear layers were observed. The layers were separated, and the aqueous layer was 
extracted 3 times with Et2O. The combined organic extracts were washed successively with sat. 
aq. Na2S2O3, water, and brine, dried over MgSO4, filtered, and concentrated under vacuum. The 
crude residue was purified via column chromatography (45% Et2O/hexanes) to afford 2.37 (802 
mg, 76%). 1H NMR (500 MHz, CDCl3) δ 6.02 (app s, 1H), 3.72 (br t, J = 6.0 Hz, 2H), 2.48 (t, J = 
6.3 Hz, 2H), 1.87 (d, J = 0.9 Hz, 3H), 1.44 (br s, 1H). The spectral data matched those previously 
reported.19 
 
(E)-4-iodo-3-methylbut-3-enal (2.38). Alcohol 2.37 (100 mg, 0.472 mmol) was taken up in 
anhydrous DCM (2.9 mL) in a reaction vessel open to air and cooled to 0 °C. NaHCO3 (198 mg, 
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2.36 mmol) was added, followed by DMP (640 mg, 1.51 mmol), and the reaction mixture was 
stirred for 1.25 hours. The mixture was diluted with pentane and quenched by the addition of a 
2:1:1 mixture of sat. aq. Na2S2O3:sat. aq. NaHCO3:water. The mixture was stirred until 2 clear 
layers were observed. The layers were separated, and the aqueous layer was extracted with 
pentane. The combined organic extracts were washed 2 times with water and 1 time with brine, 
dried over Na2SO4, filtered and concentrated under vacuum to afford aldehyde 2.38, which was 
carried forward immediately without purification. The spectral data matched those previously 
reported.19 
 
(E)-1-iodo-2,6-dimethylhepta-1,6-dien-4-ol (2.33). Grignard reagent S1 (methallylmagnesium 
chloride) was prepared as follows: 125 mg of magnesium, freshly ground with a mortar and pestle, 
was placed into a flask, which was evacuated and backfilled with argon three times. The 
magnesium was flame dried and allowed to cool. Then anhydrous THF was added to the vessel, 
followed by 0.05 mL dibromoethane. The mixture was sonicated, heated briefly, and allowed to 
cool. The vessel was then cooled to 0 °C and methallyl chloride (0.17 mL, 1.71 mmol) was added 
slowly, followed by a drop of dibromoethane. The mixture was then stirred for 1 h, coming to rt, 
and then allowed to stand for 45 min until all precipitate had settled. The supernatant solution 
titrated to 0.8 M (titration indicator: salicylaldehyde phenylhydrazone). 
The crude product 2.38 (90 mg, estimated 0.43 mmol) was dissolved in anhydrous THF and cooled 
to 0 °C. Grignard reagent S1 (0.54 mL, 0.43 mmol) was added slowly. The reaction mixture was 
stirred at rt for 1 h. The reaction was quenched by the slow addition of sat. aq. NH4Cl at 0 °C, and 
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the mixture was diluted with Et2O. The layers were separated, and the aqueous layer was extracted 
with Et2O. The combined organic extracts were washed successively with water and brine, dried 
over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified by column 
chromatography (2% →10% EtOAc/hexanes, stepwise gradient) to afford 2.33 (28 mg, 25%). The 
spectral data matched those previously observed for 2.33 (see above) as well as those previously 
reported.11 
 
(E)-6-(2-(tert-butyldimethylsilyl)furan-3-yl)-3-methylhex-3-en-1-ol (2.39). Silyl ether 2.26 
(444 mg, 1.1 mmol) was dissolved in MeOH (11 mL) in a flask open to air. TsOH·H2O (21 mg, 
0.11 mmol) was added and the reaction mixture was stirred for 1.5 h. The reaction was quenched 
by the addition of 11 mL sat. aq. NaHCO3, and the mixture was diluted with Et2O. Water was 
added until the mixture just turned to two clear layers. The layers were separated, and the aqueous 
layer was extracted four times with Et2O. The combined organic extracts were washed with brine, 
dried over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified via 
column chromatography (1% → 10% EtOAc/hexanes, stepwise gradient) to afford 2.39 as a clear 
oil. 1H NMR (500 MHz, CDCl3) δ 7.54 (s, 1H), 6.28 (s, 1H), 5.28 (t, J = 7.0 Hz, 1H), 3.65 (app s, 
2H), 2.54 (t, J = 7.7 Hz, 2H), 2.33 – 2.20 (m, J = 12.4, 6.8 Hz, 5H), 1.63 (s, 3H), 1.27 (br s, 1H), 
0.91 (s, 9H), 0.27 (s, 6H); 13C NMR (151 MHz, CDCl3) δ 153.17, 146.36, 146.35, 136.19, 132.00, 
127.49, 111.03, 60.18, 42.83, 29.71, 26.59, 26.00, 17.75, 15.89, –5.38. HRMS (ESI) m / z calcd 
for C17H30O2SiNa [M+Na]
+ 317.1913, found 317.1927. 
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(E)-tert-butyl(3-(6-iodo-4-methylhex-3-en-1-yl)furan-2-yl)dimethylsilane (2.40). Alcohol 2.39 
(200 mg, 0.68 mmol) was dissolved in anhydrous DCM (2.3 mL) and cooled to 0 °C. PPh3 (212 
mg, 0.81 mmol) and imidazole (95 mg, 1.4 mmol), were added to this solution, followed by I2 (206 
mg, 0.81 mmol). The reaction mixture was stirred for 15 min at 0 °C then for 3 h at rt. The reaction 
was quenched by the addition of sat. aq. Na2S2O3 and sat. aq. NaHCO3. The mixture was diluted 
with DCM and water and the layers were separated. The aqueous layer was extracted three times 
with DCM. The combined organic extracts were washed with brine, dried over MgSO4, filtered, 
and concentrated under vacuum. The crude residue was dry-loaded onto silica and purified via 
column chromatography (100% hexanes) to afford 2.40 (183 mg, 67%). 1H NMR (500 MHz, 
CDCl3) δ 7.55 (d, J = 1.4 Hz, 1H), 6.30 (d, J = 1.5 Hz, 1H), 5.26 (t, J = 7.1 Hz, 1H), 3.22 (t, J = 
7.7 Hz, 2H), 2.57 – 2.50 (m, 4H), 2.23 (dd, J = 15.3, 7.5 Hz, 2H), 1.60 (s, 3H), 0.91 (s, 9H), 0.26 
(s, 6H); 13C NMR (126 MHz, CDCl3) δ 153.01, 146.20, 136.17, 134.12, 126.89, 111.00, 43.85, 
29.67, 26.50, 25.82, 17.65, 15.38, 4.90, –5.47. HRMS (ESI) m / z calcd for C17H29IOSiH [M+H]+ 
405.1111, found 405.1112.  
 
Substrate 2.5. Alkyl iodide 2.40 (87 mg, 0.22 mmol) was dissolved in anhydrous Et2O (1.0 mL) 
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and cooled to –78 °C. t-BuLi (0.55 mL, 0.83 mmol, 1.5 M in pentane) was added to the solution 
quickly, followed by 9-BBN·OMe (0.75 mL, 0.75 mmol, 1.0 M in hexanes), dropwise. The 
reaction mixture was then diluted with anhydrous THF (0.3 mL) and stirred for 1 h at –78 °C then 
warmed slowly to rt and stirred for 2.5 h. The reaction vessel was then cooled to 0 °C, and K3PO4 
(0.14 mL, 0.41 mmol, 3 M in water) was added, followed by vinyl iodide 2.6 (50 mg, 17 mmol) 
as a solution in anhydrous DMF (0.31 mL) and Pd(dppf)Cl2·CH2Cl2 (20 mg, 25 μmol). The 
resultant dark green mixture was stirred overnight at rt. The reaction was quenched by the addition 
of water and brine, and the mixture was diluted with Et2O. The layers were separated and the 
aqueous layer was extracted four times with Et2O. The combined organic extracts were washed 
successively with water and brine, dried over MgSO4, filtered and concentrated under vacuum. 
The crude residue was purified via column chromatography (100 % hexanes → 10% 
EtOAc/hexanes, stepwise gradient) to afford 2.5 (60 mg, 81%). 1H NMR (500 MHz, CDCl3) δ 
7.54 (d, J = 1.6 Hz, 1H), 6.30 (d, J = 1.6 Hz, 1H), 5.25 – 5.15 (m, 2H), 4.17 – 4.07 (m, 1H), 2.76 
– 2.67 (m, 2H), 2.53 – 1.97 (m, 12H), 1.67 – 1.51 (m, 7H), 1.37 (s, 3H), 0.91 (s, 9H), 0.26 (s, 6H); 
13C NMR (151 MHz, CDCl3) δ 152.99, 146.23, 136.55, 135.32, 130.64, 128.99, 124.26, 111.17, 
58.09, 55.62, 55.47, 49.61, 45.47, 39.50, 29.78, 26.65, 26.61, 26.19, 20.45, 17.75, 16.14, 16.03, –
5.37. 
 
Substrate 2.44. Substrate 2.5 (60 mg, 0.13 mmol) was dissolved in anhydrous, degassed toluene 
(1.3 mL) at rt. Bu3SnH (0.3 mL, 1.1 mmol) and AIBN (66 mg, 0.40 mmol) were added. The 
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reaction vessel was sealed tightly and heated to 90 °C for 1.5 h, then cooled to rt. Additional 
Bu3SnH (0.15 mL) and AIBN (33 mg) were added, and the vessel was sealed and heated to 100 
°C for 5 h. The reaction mixture was cooled again to rt and the volatiles removed under vacuum. 
The crude residue was purified via column chromatography (100% hexanes → 10% 
EtOAc/hexanes) to afford 2.44 in quantitative yield (54 mg). 1H NMR (500 MHz, CDCl3) δ 7.54 
(d, J = 1.3 Hz, 1H), 6.30 (d, J = 1.5 Hz, 1H), 5.18 (t, J = 7.1 Hz, 1H), 5.10 (t, J = 6.9 Hz, 1H), 2.58 
(dd, J = 16.9, 4.9 Hz, 2H), 2.50 (dd, J = 9.1, 6.6 Hz, 2H), 2.29 – 2.18 (m, 2H), 2.11 – 1.95 (m, 
6H), 1.59 (d, J = 4.2 Hz, 6H), 1.52 – 1.43 (m, 2H), 1.31 (s, 3H), 0.91 (s, 9H), 0.26 (s, 6H); 13C 
NMR (151 MHz, CDCl3) δ 152.88, 146.12, 136.47, 135.56, 134.62, 124.65, 123.88, 111.08, 57.05, 
54.01, 39.74, 39.57, 36.31, 29.70, 26.59, 26.50, 26.11, 23.57, 21.00, 17.64, 16.08, 15.86, –5.48. 
 
(E)-tert-butyl((6-(5-(tert-butyldimethylsilyl)furan-2-yl)-3-methylhex-3-en-1-
yl)oxy)dimethylsilane (2.53). To a solution of t-BuLi (0.54 mL, 0.92 mmol, 1.7 M in pentane) in 
anhydrous Et2O (1.0 mL) at –78 °C was added alkyl iodide 2.51 (100 mg, 0.30 mmol, in 0.5 mL 
anhydrous Et2O), quickly, followed by 9-BBN·OMe (1.0 mL, 1.0 mmol, 1 M in THF), dropwise. 
The reaction mixture was diluted with 0.43 mL anhydrous THF and allowed to warm to rt, with 
stirring, over 1.25 h, then stirred at rt for 2 h. The reaction vessel was then cooled to 0 °C, and 
K3PO4 (0.19 mL, 0.58 mmol, 3 M in water) was added, dropwise, followed by vinyl iodide 2.52 
(75 mg, 0.23 mmol, in 1.2 mL anhydrous DMF), followed by Pd(dppf)Cl2·CH2Cl2 (28 mg, 35 
μmol). The reaction mixture was stirred overnight, warming to rt. The reaction vessel was then 
cooled to 0 °C and quenched by the addition of 5 mL brine and 5 mL, and the mixture was diluted 
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with 10 mL Et2O. The layers were separated and the aqueous layer was extracted with Et2O (3 × 
5 mL). The combined organic extracts were washed successively with 11 mL of water and brine, 
dried over MgSO4, filtered, and concentrated under vacuum. The crude residue was subjected to 
column chromatography (100% hexanes → 50% EtOAc/hexanes). The product-containing 
fractions were collected and concentrated under vacuum, and the resulting residue was purified 
via column chromatography (5% DCM/hexanes → 10% DCM/hexanes → 2% EtOAc/10% 
DCM/88% hexanes) to afford 2.53 (62 mg, 66%). 1H NMR (600 MHz, CDCl3) δ 6.52 (d, J = 3.0 
Hz, 1H), 5.96 (d, J = 3.0 Hz, 1H), 5.19 (t, J = 7.1 Hz, 1H), 3.67 – 3.61 (m, 2H), 2.67 (t, J = 7.6 
Hz, 2H), 2.33 (q, J = 7.4 Hz, 2H), 2.19 (t, J = 7.1 Hz, 2H), 1.59 (s, 3H), 0.90 (m, 18H), 0.20 (s, 
6H), 0.04 (s, 6H); 13C NMR (151 MHz, CDCl3) δ 160.58, 156.83, 133.20, 125.40, 121.73, 105.00, 
62.69, 43.18, 28.50, 26.77, 26.51, 26.11, 18.50, 16.94, 16.56, –5.11, –6.08. 
 
 
(E)-6-(5-(tert-butyldimethylsilyl)furan-2-yl)-3-methylhex-3-en-1-ol (2.54).  
Procedure 1: Silyl ether 2.53 (52 mg, 0.13 mmol) was dissolved in MeOH in a reaction vessel open 
to air. TsOH·H2O (2.5 mg, 13 μmol) was added, and the reaction was stirred for 1.5 h at rt. The 
reaction mixture was diluted with Et2O and quenched by the addition of water and sat. aq. 
NaHCO3. The layers were separated and the aqueous layer was extracted two times with Et2O and 
two times with EtOAc. The combined organic extracts were washed successively with water and 
brine, dried over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified 
via column chromatography (10% → 15% EtOAc/hexanes) to afford 2.54 (29 mg, 76%). 1H NMR 
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(500 MHz, CDCl3) δ 6.53 (d, J = 3.1 Hz, 1H), 5.96 (d, J = 3.0 Hz, 1H), 5.25 (t, J = 7.1 Hz, 1H), 
3.61 (q, J = 6.0 Hz, 2H), 2.71 (t, J = 7.3 Hz, 2H), 2.39 (q, J = 7.2 Hz, 2H), 2.22 (t, J = 6.1 Hz, 2H), 
1.58 (s, 3H), 0.91 (s, 9H), 0.20 (s, 6H); 13C NMR (151 MHz, CDCl3) δ 160.21, 157.17, 132.37, 
127.04, 121.74, 105.28, 60.01, 42.77, 28.41, 26.79, 26.50, 16.92, 15.76, –6.09. 
Note: the double-desilylated product (not shown) was also observed in the crude product mixture.  
Procedure 2: Silyl ether 2.53 (65 mg, 0.16 mmol) was dissolved in anhydrous THF (0.5 mL) and 
cooled to 0 °C. A drop of sat. aq. K2HPO4 was added, followed by TBAF (0.29 mL, 0.29 mmol, 1 
M in THF), dropwise. The reaction mixture was allowed to come to rt over 1 h, then stirred for a 
further 4 h at rt. The reaction was quenched by the addition of sat. aq. NH4Cl. The layers were 
separated and the aqueous layer was extracted three times with 20% EtOAc/hexanes. The 
combined organic extracts were washed successively with water and brine, dried over MgSO4, 
filtered, and concentrated under vacuum. The crude residue was purified by column 
chromatography (30% EtOAc/hexanes) to afford 2.54 (25 mg, 53%). The spectral data matched 
those obtained for the product of procedure 1, above. 
 
(E)-tert-butyl(5-(6-iodo-4-methylhex-3-en-1-yl)furan-2-yl)dimethylsilane (2.55). Alcohol 2.54 
(29 mg, 0.10 mmol) was dissolved in anhydrous DCM (0.5 mL) and cooled to 0 °C. PPh3 (34 mg, 
0.13 mmol) and imidazole (20 mg, 0.30 mmol) were added to this solution, followed by I2 (30 mg, 
0.12 mmol). The reaction mixture was stirred for 30 min at 0 °C then overnight at rt. The reaction 
was quenched by the addition of sat. aq. Na2S2O3 and sat. aq. NaHCO3. The mixture was diluted 
with DCM and water and the layers were separated. The aqueous layer was extracted three times 
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with DCM. The combined organic extracts were washed with brine, dried over MgSO4, filtered, 
and concentrated under vacuum. The crude residue was purified via column chromatography 
(100% hexanes) to afford 2.55 (29 mg, 71%). 1H NMR (500 MHz, CDCl3) δ 6.52 (d, J = 3.1 Hz, 
1H), 5.96 (d, J = 3.1 Hz, 1H), 5.25 (t, J = 7.1 Hz, 1H), 3.61 (t, J = 6.1 Hz, 2H), 2.71 (t, J = 7.3 Hz, 
2H), 2.39 (q, J = 7.2 Hz, 2H), 2.22 (t, J = 6.1 Hz, 2H), 1.58 (s, 4H), 0.91 (s, 9H), 0.20 (s, 6H); 13C 
NMR (151 MHz, CDCl3) δ 160.27, 156.97, 134.60, 126.48, 126.48, 121.75, 105.19, 43.93, 28.28, 
26.77, 26.51, 16.94, 15.45, 5.01, –6.08. 
 
Substrate 2.56. Alkyl iodide 2.55 (28 mg, 69 μmol) was dissolved in anhydrous Et2O (0.3 mL) 
and cooled to –78 °C. To this solution was added t-BuLi (0.13 mL, 0.21 mmol, 1.7 M in pentane), 
quickly, followed by 9-BBN·OMe (0.75 mL, 0.75 mmol, 1.0 M in hexanes), dropwise. The 
reaction mixture was diluted with anhydrous THF (0.2 mL) and stirred for 1 h, slowly warming 
from –78 °C, then for 3 h at rt. The reaction vessel was then cooled to 0 °C, and K3PO4 (0.05 mL, 
0.13 mmol, 3 M in water) was added, followed by vinyl iodide 2.6 (17 mg, 53 μmol) as a solution 
in anhydrous DMF (0.34 mL), then Pd(dppf)Cl2·CH2Cl2 (7 mg, 8 μmol). The reaction mixture was 
stirred overnight at rt. The reaction was quenched by the addition of water and brine, and the 
mixture was diluted with Et2O. The layers were separated and the aqueous layer was extracted 
three times with Et2O. The combined organic extracts were washed successively with water and 
brine, dried over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified 
via column chromatography (2% → 20% Et2O/hexanes, stepwise gradient) to afford 2.56 (10 mg, 
42%). 1H NMR (500 MHz, CDCl3) δ 6.52 (d, J = 3.1 Hz, 1H), 5.96 (d, J = 3.1 Hz, 1H), 5.18 (dt, 
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J = 7.1, 5.9 Hz, 2H), 4.12 (dtd, J = 10.7, 7.2, 3.4 Hz, 1H), 2.77 – 2.62 (m, 4H), 2.50 – 2.30 (m, 
4H), 2.20 (ddd, J = 14.4, 3.4, 1.2 Hz, 1H), 2.04 (dt, J = 45.9, 7.6 Hz, 4H), 1.67 – 1.48 (m, 9H), 
1.37 (s, 3H), 0.91 (s, 9H), 0.20 (s, 6H). 
 
2-(2-(tert-butyldimethylsilyl)furan-3-yl)ethan-1-ol (2.59). Zinc dust (28 mg, 0.43 mmol) was 
added to a vial which was then evacuated and backfilled with argon. Anhydrous THF (0.86 mL) 
was added, and the zinc was activated by the addition of dibromoethane and distilled TMSCl. 
Chloromethyl furan 2.11 (50 mg, 0.22 mmol) was added as a solution in anhydrous THF (0.44 
mL). The vial was sealed tightly and the reaction mixture was heated to 70 °C for 2 h, with stirring. 
The reaction vessel was allowed to cool to rt, then paraformaldehyde (20 mg, 1.3 mmol) was 
added. The reaction mixture was heated to 70 °C for 6 h. The reaction vessel was then allowed to 
cool to rt, and then further cooled to 0 °C, where the reaction was quenched by the addition of sat. 
aq. NH4Cl. The mixture was diluted with EtOAc, the layers were separated, and the aqueous layer 
was extracted three times with EtOAc. The combined organic extracts were dried over MgSO4, 
filtered, and concentrated under vacuum. The crude residue was purified via column 
chromatography (10% EtOAc/hexanes) to afford 2.59 (25 mg, 50%). 1H NMR (500 MHz, CDCl3) 
δ 7.59 (d, J = 1.5 Hz, 1H), 6.33 (d, J = 1.6 Hz, 1H), 3.79 (t, J = 6.6 Hz, 2H), 2.77 (t, J = 6.6 Hz, 
2H), 0.90 (d, J = 6.2 Hz, 9H), 0.28 (s, 6H); 13C NMR (151 MHz, CDCl3) δ 154.70, 146.80, 132.35, 
111.07, 63.33, 29.39, 26.58, 17.71, –5.29. 
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tert-butyl(3-(2-iodoethyl)furan-2-yl)dimethylsilane (2.60). Alcohol 2.59 (46 mg, 0.20 mmol) 
was dissolved in anhydrous DCM (1 mL) and cooled to 0 °C. To this solution was added PPh3 (66 
mg, 0.25 mmol) and imidazole (27 mg, 0.40 mmol), followed by I2 (63 mg, 0.25 mmol). The 
reaction mixture was stirred for 15 min at 0 °C then 3 h at rt. The reaction was quenched by the 
addition of sat. aq. Na2S2O3 and sat. aq. NaHCO3. The mixture was diluted with DCM and water 
and the layers were separated. The aqueous layer was extracted three times with DCM. The 
combined organic extracts were washed with brine, dried over MgSO4, filtered, and concentrated 
under vacuum. The crude residue was purified via column chromatography (100% hexanes) to 
afford 2.60 (47 mg, 70%). 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 0.7 Hz, 1H), 6.30 (d, J = 1.1 
Hz, 1H), 3.25 (t, J = 7.9 Hz, 2H), 3.07 (t, J = 8.0 Hz, 2H), 0.91 (s, 9H), 0.28 (s, 6H). 
 
2-(tert-butyldimethylsilyl)furan-3-carbaldehyde (2.61). Alcohol 2.24 (250 mg, 1.18 mmol) was 
dissolved in DCM (6 mL) in a flask open to air and cooled to 0 °C. Solid NaHCO3 (346 mg, 4.12 
mmol) was added, followed by DMP (999 mg, 2.35 mmol) and an additional 4 mL DCM. The 
reaction mixture was stirred for 1 h at rt. The reaction was quenched by the addition of sat. aq. 
Na2S2O3 (10 mL), and the mixture was diluted with 10 mL water. The layers were separated and 
the aqueous layer was extracted with DCM (3 × 5 mL). The combined organic extracts were 
washed with brine, dried over MgSO4, filtered, and concentrated under vacuum to afford 2.61 (245 
mg, quant). The crude product was carried forward without further purification. 1H NMR (500 
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MHz, CDCl3) δ 10.07 (s, 1H), 7.63 (dd, J = 1.7, 0.7 Hz, 1H), 6.81 (d, J = 1.7 Hz, 1H), 0.94 (s, 
9H), 0.39 (s, 6H). 
 
tert-butyldimethyl(3-vinylfuran-2-yl)silane (2.62). Methyltriphenylphosphonium bromide (539 
mg, 1.51 mmol) was placed in a round-bottom flask, which was then evacuated and backfilled 
with argon. Anhydrous THF (6 mL) was added, and the vessel was cooled to 0 °C. n-BuLi (0.56 
mL, 1.4 mmol, 2.5 M in hexanes) was added dropwise. The reaction mixture was stirred at 0 °C 
for 15 min and then at rt for 1.5 h. The reaction vessel was cooled to 0 °C and aldehyde 2.61 (245 
mg, 1.16 mmol) was added slowly as a solution in anhydrous THF (2.3 mL). The reaction mixture 
was stirred for 1 h at 0 °C. The reaction was quenched by the addition of pH 7 phosphate buffer 
(10 mL), and the mixture was diluted with 1:4 Et2O:pentane (10 mL) and water (10 mL). The 
layers were separated and the aqueous layer was extracted with the solvent mixture (3 × 9 mL). 
The combined organic extracts were washed successively with 20 mL of water and brine, dried 
over MgSO4, filtered, and concentrated under vacuum. The crude residue was purified via column 
chromatography (100% hexanes → 5% Et2O/hexanes) to afford 2.62 as a clear oil (196 mg, 81%). 
1H NMR (499 MHz, CDCl3) δ 7.55 (s, 1H), 6.73 (dd, J = 17.4, 10.8 Hz, 1H), 6.59 (s, 1H), 5.46 (d, 
J = 17.4 Hz, 1H), 5.13 (d, J = 10.8 Hz, 1H), 0.91 (s, 9H), 0.30 (s, 6H); 13C NMR (126 MHz, 
CDCl3) δ 156.37, 146.77, 135.48, 128.44, 113.51, 107.14, 26.52, 17.80, –5.47. 
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Substrate 2.46. 9-BBN (1.1 mL, 0.55 mmol, 0.5 M in THF) and anhydrous THF (0.2 mL) were 
added to a vial and cooled to 0 °C. Vinyl furan 2.62 (33 mg, 0.16 mmol) was added as a solution 
in 0.8 mL anhydrous THF. The reaction mixture was stirred for 1 h at 0 °C, then for 5 h at rt. 
K3PO4 (0.10 mL, 0.31 mmol, 3 M in water) was added, followed by vinyl iodide 2.6 (40 mg, 0.12 
mmol) as a solution in 0.6 mL anhydrous DMF, then Pd(dppf)Cl2·CH2Cl2 (15 mg, 18 μmol). The 
reaction mixture was stirred overnight at rt, then quenched by the addition of brine (2 mL) and 
water (1 mL) with vigorous stirring. The mixture was diluted with Et2O (1 mL), the layers were 
separated and the aqueous layer was extracted with Et2O (3 × 1 mL). The combined organic 
extracts were washed successively with water and brine, dried over MgSO4, filtered, and 
concentrated under vacuum. The crude residue was purified by column chromatography (6% 
EtOAc/hexanes) to afford 2.46 (11 mg, 18%). 
1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 1.6 Hz, 1H), 6.29 (d, J = 1.6 Hz, 1H), 5.28 (t, J = 7.1 
Hz, 1H), 4.13 (dtd, J = 10.8, 7.1, 3.5 Hz, 1H), 2.77 – 2.64 (m, 2H), 2.57 – 2.38 (m, 4H), 2.31 – 
2.14 (m, 3H), 1.59 (d, J = 47.2 Hz, 9H), 1.37 (s, 3H), 0.90 (s, 9H), 0.26 (s, 6H); 13C NMR (151 
MHz, CDCl3) δ 153.12, 146.32, 136.21, 131.26, 128.52, 111.08, 58.01, 55.60, 55.44, 49.58, 45.51, 
29.72, 26.60, 25.90, 20.45, 17.76, 16.06, –5.38. 
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